T and NK cells collaborate to control viral infections, discerning minute differences between infected and uninfected cells. At the same time, viruses have evolved to escape this discovery. In this issue of the JCI, Ganem and colleagues show that Kaposi sarcomaassociated herpesvirus (KSHV) inhibits CD1d presentation to T cells. This novel immune evasion strategy highlights the importance of CD1d-restricted T cells in controlling viral infection and raises an interesting question: how do T cells recognize viruses in the context of CD1 molecules that bind lipids? In the case of herpesviruses, alterations in endosomal trafficking might trigger redistribution of CD1/lipid complexes to cell surfaces, thereby promoting recognition by CD1d-restricted T cells.
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Recognition of viruses
Control of viruses by the immune system is critically dependent upon recognizing differences between infected and uninfected cells. It is also imperative that immune cells identify viruses inside cells before progeny are produced and can spread. Early recognition relies on detecting the appearance of new cell-surface markers or the loss of others. The classic examples are MHC class I and MHC class II molecules, which present peptides derived from viral proteins to T lymphocytes, which use variable TCRs to discern the viral peptides against a huge background of cellular peptides. NK cells recognize cells that lack cell-surface MHC class I molecules, a situation caused by viral inhibition of the class I pathway. Viral infection can also trigger the appearance of new molecules detectable by NK cells. For example, genes encoding MHC class I chain-related-A (MIC-A) and MIC-B proteins and UL16-binding protein (ULBP) are coupled to hair-trigger promoters that are "tripped" by viruses so that cell-surface MIC proteins and ULBPs are detected by NK group 2D (NKG2D) receptors on NK and CD8 + T cells (1).
Viral immune evasion
As the immune system endeavors to recognize the presence of a virus inside cells, 
CD1, CD1-restricted T cells, and viruses
CD1 proteins are MHC class I molecules that present lipids and glycolipids to T cells through their TCRs (6, 7) . Recognition of CD1 in the context of viral infection is not well understood. Human CD1 molecules are encoded by 5 genes, CD1A, CD1B, CD1C, CD1D, and CD1E, and each protein has different lipid-binding specificities and trafficking properties. CD1d-restricted T cells include NK T cells that express CD161 (corresponding to NK1.1) and frequently possess invariant TCRs as well as T cells with diversely rearranged TCRs (6, 7). It is well established that CD1-and CD1d-restricted T cells play essential or important roles in controlling bacterial infections, especially in the case of infection with mycobacteria (6) (7) (8) . Control of such infection can be readily understood, as bacteria express novel lipid antigens. Bacterial glycolipids are largely taken up into endosomes and lysosomes before being loaded onto CD1 (6). A lipid derived from a marine sponge, α-galactosylceramide (α-GalCer), is also a potent antigen for CD1d-restricted T cells and has been used to stimulate both antibacterial and antiviral immunity (9) . However, there is substantial evidence that lipids derived from host cell membranes can stimulate CD1-restricted T cells (6) . Frequently activated in early phases of the immune response, CD1-restricted T cells stimulate NK, T, and B cells, macrophages, and DCs through IFN-γ, IL-2, and IL-4. These T cells are also potently cytolytic and able to release perforin and granzymes and utilize Fas/Fas ligand to kill cells.
CD1-and CD1d-restricted T cells also appear to play important roles in controlling viral infections. CD1d -/-mice exhibit reduced clearance and increased pathology after infection with respiratory syncytial virus, encephalomyocarditis virus, and coxsackievirus B3 (7-9). CD1-restricted T cells also induce immunopathology or have limited effects on viral infections (10). However, some of the clearest evidence in support of an essential role for CD1d-restricted T cells has come from studies of herpesviruses. Herpes simplex virus-1 (HSV-1) and HSV-2 produce much more profound pathology in CD1d -/-mice, with markedly increased virus replication and pathology in epithelial tissues, spread to the nervous system, and encephalitis (11, 12) . Murine cytomegalovirus replication is reduced in mice treated with α-GalCer (10). Moreover, a patient lacking NK T cells (and with no other obvious immunodeficiencies) presented with disseminated varicella zoster virus (VZV) after vaccination with attenuated virus (13) .
Despite evidence that CD1-restricted T cells are involved in antiviral immunity, it
is not yet understood how CD1-restricted T cells recognize virus-infected cells. Bacteria express novel lipids, but there is little evidence that viral infections lead to substantial modification of the lipid content of host cells. While many viral proteins are fatty acid modified and glycophosphatidylinositol anchored, these modifications are unlikely to be specific to viruses because cellular proteins are similarly modified. There is evidence that CD1d-restricted T cells are activated without direct recognition of pathogen-derived lipids. This occurs through stimulation by weak selflipid responses presented via CD1d and is then amplified by IL-12 produced by DCs when they detect bacterial products (14) . According to this model, recognition of pathogens is achieved by other cells, and CD1-restricted T cells are indirectly stimulated to express cytokines. However, there are also indications that CD1-restricted T cells can recognize virus-infected cells. For example, CD1-restricted T cells are frequently cytolytic and thus capable of directly interacting with and killing virusinfected cells (6) (7) (8) (9) .
KSHV inhibition of CD1d-restricted T cell recognition
In this issue of the JCI, Ganem and colleagues describe loss of cell-surface CD1d in cells infected with KSHV (15) . KSHV proteins modulator of immune recognition-1 (MIR1) and MIR2 (also known as K3 and K5, respectively) caused cell-surface CD1d to be internalized by a process dependent on both the presence of dynamin and the ubiquitination of a CD1d cytoplasmic lysine. Internalized CD1d was relatively stable and was not immediately degraded in lysosomes (15) . Previous observations from this laboratory demonstrated that MIR2 also promotes internalization of MHC class I, B7.2, and ICAM-1 molecules (16, 17) . Not only does MIR2 reduce cell-surface CD1d, but it also inhibits recognition by CD1d-restricted T cells. These results are especially interesting because, as the authors point out, they reinforce the notion that CD1d in virus-infected cells can signal directly to T cells. Otherwise, why would KSHV infection pull CD1d off the cell surface, a process that can only benefit the virus in infected cells, and not in some other APC that is not infected?
Promiscuity of viral immune evasion proteins
The results of Sanchez, Gumperz, and Ganem (15) highlight another emerging principle of viral immune evasion. Initial reports describing inhibitors of the MHC class I pathway tended to ignore effects of viral proteins on other MHC and non-MHC molecules (2). However, as work has progressed, it has become clear that many viral immune evasion proteins bind multiple cellular targets, thereby preventing recognition by several pathways (3, 4) . One of the best examples is human cytomegalovirus (HCMV) glycoprotein unique short region open reading frame 2 (US2) that induces degradation of several diverse MHC class I molecules (HLA-A, HLA-B, HLA-C, HLA-E, and HLA-G), as well as MHC class IIα chains (but not β or invariant chains), HLA-DMα, and the hemochromatosis protein (see Table 1 ). (6) . CD1 molecules that cannot be internalized because they lack cytoplasmic domains or are expressed in cells without certain clathrin adaptors cannot present lipids to T cells (6) . Thus, in our model depicted in Figure 1A , the immunologically relevant lipids recognized by CD1-restricted T cells are loaded onto CD1 in endosomes or lysosomes. Other lipids, e.g. phosphatidylinositol, are loaded onto nascent CD1 molecules in the ER and are less antigenic. Moreover, CD1 molecules are rapidly endocytosed from plasma membranes, and the bulk of these molecules amass in endosomal or lysosomal vesicles, not on the cell surface (6). Structural proteins from herpesviruses, including HSV, VZV, and HCMV, extensively accumulate in the trans-Golgi network (TGN) and endosomes (19) . Virus particles are assembled on the surfaces of the TGN and endosomes, causing enveloped virions to bud into cytoplasmic vesicles and later be transported to the cell surface ( Figure 1B) . At intermediate-to-late stages of HSV replication, both cellular and viral TGN/ endosomal proteins are redistributed to the cell surface (20) . This redistribution is apparently produced through the action of HSV proteins that disrupt traffic so that endosomal proteins move to the cell surface, taking virus particles along for the ride. This egress pathway appears to be a basic process of all herpesviruses. We propose that substantial quantities of CD1 are relocalized from endosomes to the cell surface after herpesvirus infection ( Figure 1B ). By this model, CD1-bearing endosomal lipids emerge in substantial quantities on the cell surface and signal that viruses are present and have disrupted endosomal traffic. Redistribution of CD1 molecules from endosomes to the cell surface could be a general feature of other viral infections. Poxviruses and HIV can also assemble in endosomes (19, 21) . This model of CD1 as a molecular flag is analogous to the role of MIC-A and MIC-B proteins, which signal to T and NK cells upon viral infection (1) . However, as with all immune recognition events, herpesviruses counter with viral inhibitors that promote invisibility, at least for a time. 
